Tiago Fauth
Stock Analyst at Raymond James
(4.48)
# 1,128
Out of 4,792 analysts
299
Total ratings
48.7%
Success rate
12.2%
Average return
Main Sectors:
Stocks Rated by Tiago Fauth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $87 → $84 | $56.02 | +49.95% | 3 | Sep 8, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $945 | $345.30 | +173.68% | 3 | Aug 17, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $66 → $75 | $43.89 | +70.90% | 2 | Aug 17, 2026 | |
| PLYX Polaryx Therapeutics | Initiated Coverage: Buy | $6 | $2.08 | +188.46% | 1 | Aug 13, 2026 | |
| TNXP Tonix Pharmaceuticals Holding | Reiterated: Buy | $26 → $27 | $12.83 | +110.44% | 2 | Aug 10, 2026 | |
| MPLT MapLight Therapeutics | Initiated Coverage: Buy | $46 | $13.71 | +235.52% | 1 | Jun 25, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $76 → $98 | $76.08 | +28.81% | 18 | Jun 17, 2026 | |
| INSM Insmed | Reiterated: Buy | $200 → $185 | $128.80 | +43.63% | 23 | May 8, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $108 → $95 | $67.57 | +40.59% | 22 | May 8, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $227 → $239 | $241.31 | -0.96% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.07 | +460.75% | 1 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $414 → $700 | $506.82 | +38.12% | 26 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $11.31 | +76.83% | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $3.94 | +77.66% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $18 | $4.81 | n/a | 11 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $31 | $69.12 | n/a | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $30.48 | n/a | 7 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $333 → $395 | $258.00 | n/a | 13 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $65 | $14.31 | n/a | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $5.42 | n/a | 4 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $76.51 | n/a | 5 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $1.15 | n/a | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $11.31 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 → $70 | $19.06 | n/a | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $89 | $260.81 | n/a | 22 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 | $64.41 | n/a | 8 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $22.73 | n/a | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $55.74 | n/a | 4 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $26 | $12.09 | n/a | 6 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $28 | $11.05 | n/a | 9 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 | $2.09 | n/a | 6 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $34 | $1.84 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $26.27 | n/a | 3 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $4.02 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 → $13 | $2.77 | n/a | 4 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $14 | $3.38 | n/a | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $14 | $8.65 | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $340 → $319 | $1,002.31 | n/a | 9 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $12 → $7 | $38.75 | n/a | 7 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $259 | $391.27 | n/a | 2 | Apr 28, 2021 |
Ionis Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $87 → $84
Current: $56.02
Upside: +49.95%
Praxis Precision Medicines
Aug 17, 2026
Reiterated: Buy
Price Target: $945
Current: $345.30
Upside: +173.68%
Rapport Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $66 → $75
Current: $43.89
Upside: +70.90%
Polaryx Therapeutics
Aug 13, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $2.08
Upside: +188.46%
Tonix Pharmaceuticals Holding
Aug 10, 2026
Reiterated: Buy
Price Target: $26 → $27
Current: $12.83
Upside: +110.44%
MapLight Therapeutics
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $13.71
Upside: +235.52%
BridgeBio Pharma
Jun 17, 2026
Reiterated: Buy
Price Target: $76 → $98
Current: $76.08
Upside: +28.81%
Insmed
May 8, 2026
Reiterated: Buy
Price Target: $200 → $185
Current: $128.80
Upside: +43.63%
PTC Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $108 → $95
Current: $67.57
Upside: +40.59%
Jazz Pharmaceuticals
May 6, 2026
Reiterated: Buy
Price Target: $227 → $239
Current: $241.31
Upside: -0.96%
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $1.07
Upside: +460.75%
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $414 → $700
Current: $506.82
Upside: +38.12%
Mar 5, 2026
Reiterated: Buy
Price Target: $26 → $20
Current: $11.31
Upside: +76.83%
Feb 27, 2026
Reiterated: Buy
Price Target: $10 → $7
Current: $3.94
Upside: +77.66%
Sep 4, 2025
Reiterated: Buy
Price Target: $21 → $18
Current: $4.81
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $25 → $31
Current: $69.12
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $101
Current: $30.48
Upside: n/a
Aug 1, 2025
Reiterated: Hold
Price Target: $333 → $395
Current: $258.00
Upside: n/a
Jul 9, 2025
Reiterated: Buy
Price Target: $88 → $65
Current: $14.31
Upside: n/a
May 28, 2025
Reiterated: Buy
Price Target: $8 → $7
Current: $5.42
Upside: n/a
May 8, 2025
Reiterated: Buy
Price Target: $91
Current: $76.51
Upside: n/a
Mar 4, 2025
Reiterated: Hold
Price Target: $4 → $3
Current: $1.15
Upside: n/a
Aug 22, 2024
Initiated Coverage: Hold
Price Target: $16
Current: $11.31
Upside: n/a
Jun 17, 2024
Downgraded: Hold
Price Target: $35 → $70
Current: $19.06
Upside: n/a
Jun 13, 2023
Initiated Coverage: Hold
Price Target: $89
Current: $260.81
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $120
Current: $64.41
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $51
Current: $22.73
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $4
Current: $55.74
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $29 → $26
Current: $12.09
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $34 → $28
Current: $11.05
Upside: n/a
Apr 5, 2023
Reiterated: Sell
Price Target: $2
Current: $2.09
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $38 → $34
Current: $1.84
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $7 → $6
Current: $26.27
Upside: n/a
Dec 16, 2022
Initiated Coverage: Buy
Price Target: $13
Current: $4.02
Upside: n/a
Nov 17, 2022
Downgraded: Hold
Price Target: $33 → $13
Current: $2.77
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $19 → $14
Current: $3.38
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $28 → $14
Current: $8.65
Upside: n/a
Mar 3, 2022
Reiterated: Hold
Price Target: $340 → $319
Current: $1,002.31
Upside: n/a
Aug 2, 2021
Downgraded: Sell
Price Target: $12 → $7
Current: $38.75
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $265 → $259
Current: $391.27
Upside: n/a